Human rhinovirus 3C protease: Generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening

Journal of Chemical Information and Modeling

Volumn 45, Issue 3, 2005, Pages 716-724

  Steindl, Theodora ^a   Laggner, Christian ^a   Langer, Thierry ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL BONDS; COMPUTER SOFTWARE; DATABASE SYSTEMS; ENZYME INHIBITION; ENZYMES; SCREENING;

HUMAN RHINOVIRUS (HRV); NONPEPTIDIC INHIBITORS; PHARMACOPHORE; PROTEASE;

VIRUSES;

PEPTIDE HYDROLASE; PROTEINASE INHIBITOR;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; RHINOVIRUS;

BINDING SITES; MODELS, MOLECULAR; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; RHINOVIRUS;

EID: 20444377675     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci049638a     Document Type: Article

References (28)

1. Webber, S. E.; Tikhe, J.; Worland, S. T.; Fuhrman, S. A.; Hendrickson, T. F. et al. Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease. J. Med Chem. 1996, 39, 5072-5082.
2. Hernandez, A. A.; Roush, W. R. Recent advances in the synthesis, design and selection of cysteine protease inhibitors. Curr. Opin. Chem. Biol. 2002, 6, 459-465.
3. Matthews, D. A.; Dragovich, P. S.; Webber, S. E.; Fuhrman, S. A.; Patick, A. K. et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 11000-11007.
4. Kaldor, S. W.; Hammond, M.; Dressman, B. A.; Labus, J. M.; Chadwell, F. W. et al. Glutamine-Derived Aldehydes for the Inhibtion of Human Rhinovirus 3C Protease. Bioorg. Med. Chem. Lett. 1995, 5, 2021-2026.
5. Anand, K.; Ziebuhr, J.; Wadhwani, P.; Mesters, J. R.; Hilgenfeld, R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300, 1763-1767.
6. Zhang, X. W.; Yap, Y. L. Exploring the binding mechanism of the main proteinase in SARS-associated Coronavirus and its implication to anti-SARS drug design. Bioorg. Med. Chem. 2004, 12, 2219-2223.
7. Jenwitheesuk, E.; Samudrala, R. Identifying inhibitors of the SARS coronavirus proteinase. Bioorg. Med. Chem. Lett. 2003, 13, 3989-3992.
8. Dragovich, P. S.; Prins, T. J.; Zhou, R.; Fuhrman, S. A.; Patick, A. K. et al. Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 3. Structure-Activity Studies of Ketomethylene-Containing Peptidomimetics. J. Med. Chem. 1999, 42, 1203-1212.
9. Xian, M.; Wang, Q. M.; Chen, X.; Wang, K.; Wang, P. G. S-Nitrosothiols as Novel, Reversible Inhibitors of Human Rhinovirus 3C Protease. Bioorg. Med. Chem. Lett. 2000, 10, 2097-2100.
10. Dragovich, P. S.; Prins, T. J.; Zhou, R.; Brown, E. L.; Maldonado, F. C. et al. Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure-Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics. J. Med. Chem. 2002, 45, 1607-1623.
11. Dragovich, P. S.; Prins, T. J.; Zhou, R.; Johnson, O. T.; Hua, Y. et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. J. Med. Chem. 2003, 46, 4572-4585.
12. Dragovich, P. S.; Prins, T. J.; Zhou, R.; Johnson, T. O.; Brown, E. L. et al. Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure-Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics. Bioorg. Med. Chem. Lett. 2002, 12, 733-738.
13. Reich, S. H.; Johnson, T.; Wallace, M. B.; Kephart, S. E.; Fuhrman, S. A. et al. Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease: Structure-Based Design, Synthesis, and Biological Evaluation. J. Med. Chem. 2000, 43, 1670-1683.
14. Singh, S. B.; Cordingley, M., G.; Ball, R. G.; Smith, J. L. M.; Dombrowski, A. W. et al. Structure and stereochemistry of thysanone: a novel human rhinovirus 3C-protease inhibitor from Thysanophora penicilloides. Tetrahedron Lett. 1991, 32, 5279-5282.
15. Kadam, S.; Poddig, J.; Humphrey, P.; Karwowski, J.; Jackson, M. et al. Citrinin hydrate and radicinin: human rhinovirus 3C-protease inhibitors discovered in a target-directed microbial screen. J. Antibiot. 1994, 47, 836-839.
16. Brill, G. M.; Kati, W. M.; Montgomery, D.; Karwowski, J. P.; Humphrey, P. E. et al. Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screen. J. Antibiot. 1996, 49, 541-546.
17. Jungheim, L. N.; Cohen, J. D.; Johnson, R. B.; Villarreal, E. C.; Wakulchik, M. et al. Inhibition of Human Rhinovirus 3C Protease by Homophthalimides. Bioorg. Med. Chem. Lett. 1997, 7, 1589-1594.
18. Johnson, T. O.; Hua, Y.; Luu, H. T.; Brown, E. L.; Chan, F. et al. Structure-Based Design of a Parallel Synthetic Array Directed Toward the Discovery of Irreversible Inhibitors of Human Rhinovirus 3C Protease. J. Med. Chem. 2002, 45, 2016-2023.
19. Hill, R. D.; Vederas, J. C. Azodicarboxamides: A New Class of Cysteine Protease Inhibitor for Hepatitis A Virus and Human Rhinovirus 3C Enzymes. J. Org. Chem. 1999, 64, 9538-9546.
20. Singh, S. B.; Graham, P. L.; Reamer, R. A.; Cordingley, M. G. Discovery, Total Synthesis, HRV 3C-Protease Inhibitory Activity, and Structure-Activity Relationships of 2-Methoxystypandrone and Its Analogues. Bioorg. Med. Chem. Lett. 2001, 11, 3143-3146.
21. Accelrys Inc., Catalyst, version 4.7, San Diego 2002. http://www.accelrys.com.
22. Shepherd, T. A.; Cox, G. A.; McKinney, E.; Tang, J.; Wakulchik, M. et al. Small Peptidic Aldehyde Inhibitors of Human Rhinovirus 3C Protease. Bioorg. Med. Chem. Lett. 1996, 6, 2893-2896.
23. Webber, S. E.; Okano, K.; Little, T. L.; Reich, S. H.; Xin, Y.; Fuhrman, S. A. et al. Tripeptide Aldehyde Inhibitors of Human Rhinovirus 3C Protease: Design, Synthesis, Biological Evaluation, and Cocrystal Structure Solution of P1 Glutamine Isosteric Replacements. J. Med. Chem. 1998, 41, 2786-2805.
24. Brookhaven National Laboratory: Protein Data Bank, http://www.rcsb.org/ pdb/.
25. Derwent World Drug Index, http://www.derwent.com/.
26. Webber, S. E.; Marakovits, J. T.; Dragovich, P. S.; Prins, T. J.; Zhou, R. et al. Design and Synthesis of Irreversible Depsipeptidyl Human Rhinovirus 3C Protease Inhibitors. Bioorg. Med. Chem. Lett. 2001, 11, 2683-2686.
27. Maybridge Database, Tintagel, http://www.maybridge.com/.
28. Interbioscreen Database, Moscow, http://www.ibscreen.com/.